1Dubois J,Pierre CS.Comparative in vitro activity and post-antibiotic effect of gemifloxacin against Legionella spp[J].J Antimicrob Chemother,2000,45(1):41-46. 被引量：1
2Stout JE,Arnold B,Yu VL.Activity of azithromycin,clarithromycin,roxithromycin,dirithromycin,quinupristin/dalfopristin and erythro-mycin against Legionella species by intracellular susceptibility testing in HL-60cells[J].J Antimicrob Chemother,1998,41(3):289-291. 被引量：1
3Szysz MP,Pinkosz MC.Occurrence and pathogenicity of the family of Legionellaceae[J].Postepy Hig Med Dosw,2008,62(3):337-353. 被引量：1
4Tano E,Cars O,wdin EL.Pharmacodynamic studies of moxifloxacin and erythromycin against intracellular Legionella pneumophila in an in vitro kinetic model[J].J Antimicrob Chemother,2005,56(2):240-242. 被引量：1
6Almahmoud I,Kay E,Schneider D,et al.Mutational paths towards increased fluoroquinolone resistance in Legionella pneumophila[J].J Antimicrob Chemother,2009,64(3):284–293. 被引量：1
7Garcia MT,Pelaz C,Gimenez MJ,et al.In vitro activities of gemifloxacin versus five quinolones and two macrolides against271Spanish isolates of Legionella pneumophila:influence of charcoal on susceptibility test results[J].Antimicrob Agents Chemother,2000,44(8):2176–2178. 被引量：1
8Onody C,Bernard PM,Nauciel C.Lack of resistance to erythromycin,rifampicin and ciprofloxacin in98clinical isolates of Legionella pneumophila[J].J Antimicrob Chemother,1997,39(6):815–816. 被引量：1
9Rayamajhi N,Joo JC,Cha SB,et al.Enzymatic analysis of the effect of naturally occurring Leu138Pro mutation identified in SHV beta-lactamase on hydrolysis of penicillin and ampicillin[J].BMC Microbiol,2011,11(29):1-7. 被引量：1
10Bulkley D,Innis CA,Blaha G,et al.Revisiting the structures of several antibiotics bound to the bacterial ribosome[J].Proc Natl Acad Sci U S A,2010,107(40):17158-17163. 被引量：1
7Uriarte S M,Molestina R E,Miller R D,et al.Effect of macrolide antibiotics on human endothelial cells activated by chlamydia pneumonia infection and tumor necrosis factor-alpha[J].J Infect Dis,2002,185 (11):1631-1636. 被引量：1
8Doem G,Brueggemann A B,Huynh H,et al.Antimicobial resistance with Streptococus pneumoniate in the United States,1997-1998[J].Emerging Infect Dis,1999,5 (2):757-765. 被引量：1
9Schito G C,Marchese A,Elkharrat D,et al.Comparative activity of telithromycin against macrolide-resistant isolates of Streptococcus pneumoniae:results of two years of the PROTEKT surveiUance study[J].J Chemother,2004,16(1):13-22. 被引量：1
10Waites K,Brown S.Antimicrobial resistance among isolates of respiratory tract infection pathogens from the southern united states:data from the PROTEKT US surveillance program 2000/ 2001[J].South Med J,2003,96(10):974-985. 被引量：1
2Niederman MS,Mandell LA,Anzueto A,et al.Guidelines for the management of adults with community-acquired pneumonia.Diagnosis,assessment of severity,antimicrobial thereapy,and prevention[J].Am J Respir Crit Care Med,2001,163:1730-1754. 被引量：1
